Rachel L. Clement
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rachel L. Clement has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Peter T. Sage
Transplantation Research Center, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
4 shared publications Alos Diallo
Department of Immunology, Harvard Medical School, Boston, USA
3 shared publications- David A. Hill
Division of Allergy and Immunology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
3 shared publications Amanda B. Muir
2 shared publications- Arlene H. Sharpe
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
2 shared publications Cecilia B. Cavazzoni
Transplantation Research Center, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
2 shared publications
Latest Publications
- 6 February 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (2)
Featured Cover
- Open Access
- 22 December 2025
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (2) , 124-136
Oesophageal Epithelial Cell‐Intrinsic MHCII Regulates Food Antigen‐Dependent Eosinophilic Esophagitis in an IFN γ‐Dependent Manner
Background: Eosinophilic oesophagitis (EoE) is a chronic food allergy that causes oesophageal inflammation and dysfunction. Recent work demonstrates IFNγ‐dependent gene signatures in inflamed EoE biopsies. IFNγ has been implicated in the promotion of MHCII expression on oesophageal epithelial cells (EECs). However, the regulation of EEC‐MHCII expression in vivo, and its contribution to EoE, is unknown. Objective: The objective of this study was to determine the regulation and role of EEC‐intrinsic MHCII expression in EoE. Methods: We examined the expression of HLA II‐pathway transcripts in human EECs using single cell RNA‐seq datasets and primary human tissues and mouse systems to interrogate the contribution of IFNγ to EEC‐MHCII expression. Finally, we used a mouse disease model to test the contribution of epithelial MHCII to food antigen‐dependent EoE. Results: HLA II transcripts were upregulated in EECs of active EoE patients, compared with controls. Similarly, EEC‐MHCII expression was higher in mice with EoE‐like inflammation. EEC‐MHCII expression was governed by IFNγ‐responsive transcriptional regulation. EEC‐specific MHCII deficiency resulted in exacerbated eosinophilic inflammation in a model of food antigen‐dependent EoE. Conclusion: We find a novel immunoregulatory role for IFNγ‐dependent EEC‐MHCII in the context of oesophageal food allergy. Clinical Relevance: Our results expand our understanding of oesophageal immune physiology and identify EEC‐MHCII as mediating an anti‐inflammatory axis that could be leveraged therapeutically.
- 22 December 2025
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (2) , 124-136
Open AccessOesophageal Epithelial Cell‐Intrinsic MHCII Regulates Food Antigen‐Dependent Eosinophilic Esophagitis in an IFN γ‐Dependent Manner
Background: Eosinophilic oesophagitis (EoE) is a chronic food allergy that causes oesophageal inflammation and dysfunction. Recent work demonstrates IFNγ‐dependent gene signatures in inflamed EoE biopsies. IFNγ has been implicated in the promotion of MHCII expression on oesophageal epithelial cells (EECs). However, the regulation of EEC‐MHCII expression in vivo, and its contribution to EoE, is unknown. Objective: The objective of this study was to determine the regulation and role of EEC‐intrinsic MHCII expression in EoE. Methods: We examined the expression of HLA II‐pathway transcripts in human EECs using single cell RNA‐seq datasets and primary human tissues and mouse systems to interrogate the contribution of IFNγ to EEC‐MHCII expression. Finally, we used a mouse disease model to test the contribution of epithelial MHCII to food antigen‐dependent EoE. Results: HLA II transcripts were upregulated in EECs of active EoE patients, compared with controls. Similarly, EEC‐MHCII expression was higher in mice with EoE‐like inflammation. EEC‐MHCII expression was governed by IFNγ‐responsive transcriptional regulation. EEC‐specific MHCII deficiency resulted in exacerbated eosinophilic inflammation in a model of food antigen‐dependent EoE. Conclusion: We find a novel immunoregulatory role for IFNγ‐dependent EEC‐MHCII in the context of oesophageal food allergy. Clinical Relevance: Our results expand our understanding of oesophageal immune physiology and identify EEC‐MHCII as mediating an anti‐inflammatory axis that could be leveraged therapeutically.
- Open Access
IFNγ Signaling Impairs Regulatory B Cell Function Resulting in Worse Control of Esophageal Food Allergy
Background: Eosinophilic Esophagitis (EoE) is a chronic food allergy that causes esophageal inflammation and fibrosis and manifests with symptoms of reflux, chest pain, swallowing difficulty, and food impactions. Though the prevalence of EoE is increasing by ~15% each year, our understanding of EoE immunopathology is limited. A noted feature of EoE is the presence of food‐specific IgG4 antibodies in the circulation and esophageal tissue. Production of IgG4 is confined to IL‐10+ B cells (Bregs) in other allergic diseases, suggesting Bregs may be present in EoE.Methods: We examined circulating Bregs in patients with EoE milk allergy. In parallel, we performed mechanistic investigations of the role of Bregs in a murine model of food‐antigen‐dependent EoE. Flow cytometry and histologic analyses were used to assess esophageal and draining lymph node immune cells, and in vitro assays were used to evaluate Breg functional capacity.Results: Breg frequency was reduced in both EoE milk allergic subjects and an EoE disease model. Murine Breg suppressive capacity was impaired during EoE‐like inflammation. Inducible deletion of Breg‐derived IL‐10 worsened EoE‐like inflammation, while adoptive transfer of IL‐10 sufficient Bregs suppressed DC activation and improved esophageal eosinophilia. IFNγ was sufficient to suppress Breg expansion and IL‐10 production in vitro and contributed to Breg dysfunction and esophageal inflammation in vivo.Conclusion: Bregs play an immunoregulatory role during EoE by controlling esophageal eosinophilia but are functionally impaired due to IFNγ‐mediated signaling. These findings have important implications for understanding EoE's etiology and implementing future therapies that target IFNγ.
Open AccessIFNγ Signaling Impairs Regulatory B Cell Function Resulting in Worse Control of Esophageal Food Allergy
Background: Eosinophilic Esophagitis (EoE) is a chronic food allergy that causes esophageal inflammation and fibrosis and manifests with symptoms of reflux, chest pain, swallowing difficulty, and food impactions. Though the prevalence of EoE is increasing by ~15% each year, our understanding of EoE immunopathology is limited. A noted feature of EoE is the presence of food‐specific IgG4 antibodies in the circulation and esophageal tissue. Production of IgG4 is confined to IL‐10+ B cells (Bregs) in other allergic diseases, suggesting Bregs may be present in EoE.Methods: We examined circulating Bregs in patients with EoE milk allergy. In parallel, we performed mechanistic investigations of the role of Bregs in a murine model of food‐antigen‐dependent EoE. Flow cytometry and histologic analyses were used to assess esophageal and draining lymph node immune cells, and in vitro assays were used to evaluate Breg functional capacity.Results: Breg frequency was reduced in both EoE milk allergic subjects and an EoE disease model. Murine Breg suppressive capacity was impaired during EoE‐like inflammation. Inducible deletion of Breg‐derived IL‐10 worsened EoE‐like inflammation, while adoptive transfer of IL‐10 sufficient Bregs suppressed DC activation and improved esophageal eosinophilia. IFNγ was sufficient to suppress Breg expansion and IL‐10 production in vitro and contributed to Breg dysfunction and esophageal inflammation in vivo.Conclusion: Bregs play an immunoregulatory role during EoE by controlling esophageal eosinophilia but are functionally impaired due to IFNγ‐mediated signaling. These findings have important implications for understanding EoE's etiology and implementing future therapies that target IFNγ.
- Open Access
- 24 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states
Follicular helper T (Tfh) cells are essential for the formation of high affinity antibodies after vaccination or infection. Although the signals responsible for initiating Tfh differentiation from naïve T cells have been studied, the signals controlling sequential developmental stages culminating in optimal effector function are not well understood. Here we use fate mapping strategies for the cytokine IL-21 to uncover sequential developmental stages of Tfh differentiation including a progenitor-like stage, a fully developed effector stage and a post-effector Tfh stage that maintains transcriptional and epigenetic features without IL-21 production. We find that progression through these stages are controlled intrinsically by the transcription factor FoxP1 and extrinsically by follicular regulatory T cells. Through selective deletion of Tfh stages, we show that these cells control antibody dynamics during distinct stages of the germinal center reaction in response to a SARS-CoV-2 vaccine. Together, these studies demonstrate the sequential phases of Tfh development and how they promote humoral immunity.
- 24 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Open AccessStepwise differentiation of follicular helper T cells reveals distinct developmental and functional states
Follicular helper T (Tfh) cells are essential for the formation of high affinity antibodies after vaccination or infection. Although the signals responsible for initiating Tfh differentiation from naïve T cells have been studied, the signals controlling sequential developmental stages culminating in optimal effector function are not well understood. Here we use fate mapping strategies for the cytokine IL-21 to uncover sequential developmental stages of Tfh differentiation including a progenitor-like stage, a fully developed effector stage and a post-effector Tfh stage that maintains transcriptional and epigenetic features without IL-21 production. We find that progression through these stages are controlled intrinsically by the transcription factor FoxP1 and extrinsically by follicular regulatory T cells. Through selective deletion of Tfh stages, we show that these cells control antibody dynamics during distinct stages of the germinal center reaction in response to a SARS-CoV-2 vaccine. Together, these studies demonstrate the sequential phases of Tfh development and how they promote humoral immunity.
- Open Access
- 1 February 2022
- Published by Elsevier in Cell Reports
- Vol. 38 (8) , 110399
Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice
- 1 February 2022
- Published by Elsevier in Cell Reports
- Vol. 38 (8) , 110399
Open AccessFollicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice
- Top Cited Papers
Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity
- 2 September 2019
- Published by Springer Nature in Nature Immunology
- Vol. 20 (10) , 1360-1371
Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses
Follicular regulatory T (TFR) cells have specialized roles in modulating follicular helper T (TFH) cell activation of B cells. However, the precise role of TFR cells in controlling antibody responses to foreign antigens and autoantigens in vivo is still unclear due to a lack of specific tools. A TFR cell-deleter mouse was developed that selectively deletes TFR cells, facilitating temporal studies. TFR cells were found to regulate early, but not late, germinal center (GC) responses to control antigen-specific antibody and B cell memory. Deletion of TFR cells also resulted in increased self-reactive immunoglobulin (Ig) G and IgE. The increased IgE levels led us to interrogate the role of TFR cells in house dust mite models. TFR cells were found to control TFH13 cell-induced IgE. In vivo, loss of TFR cells increased house-dust-mite-specific IgE and lung inflammation. Thus, TFR cells control IgG and IgE responses to vaccines, allergens and autoantigens, and exert critical immunoregulatory functions before GC formation.
- 2 September 2019
- Published by Springer Nature in Nature Immunology
- Vol. 20 (10) , 1360-1371
Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses
Follicular regulatory T (TFR) cells have specialized roles in modulating follicular helper T (TFH) cell activation of B cells. However, the precise role of TFR cells in controlling antibody responses to foreign antigens and autoantigens in vivo is still unclear due to a lack of specific tools. A TFR cell-deleter mouse was developed that selectively deletes TFR cells, facilitating temporal studies. TFR cells were found to regulate early, but not late, germinal center (GC) responses to control antigen-specific antibody and B cell memory. Deletion of TFR cells also resulted in increased self-reactive immunoglobulin (Ig) G and IgE. The increased IgE levels led us to interrogate the role of TFR cells in house dust mite models. TFR cells were found to control TFH13 cell-induced IgE. In vivo, loss of TFR cells increased house-dust-mite-specific IgE and lung inflammation. Thus, TFR cells control IgG and IgE responses to vaccines, allergens and autoantigens, and exert critical immunoregulatory functions before GC formation.
- Open Access
- 31 January 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (3) , 605-620
FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program
Follicular regulatory T (Tfr) cells are a regulatory T cell subset that controls antibody production by inhibiting T follicular helper (Tfh)–mediated help to B cells. Tfh and Tfr cells possess opposing functions suggesting unique programming. Here we elucidated the transcriptional program controlling Tfr suppressive function. We found that Tfr cells have a program for suppressive function fine-tuned by tissue microenvironment. The transcription factor FoxP3 and chromatin-modifying enzyme EZH2 are essential for this transcriptional program but regulate the program in distinct ways. FoxP3 modifies the Tfh program to induce a Tfr-like functional state, demonstrating that Tfr cells coopt the Tfh program for suppression. Importantly, we identified a Tfr cell population that loses the Tfr program to become “ex-Tfr” cells with altered functionality. These dysfunctional ex-Tfr cells may have roles in modulating pathogenic antibody responses. Taken together, our studies reveal mechanisms controlling the Tfr transcriptional program and how failure of these mechanisms leads to dysfunctional Tfr cells.
- 31 January 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (3) , 605-620
Open AccessFoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program
Follicular regulatory T (Tfr) cells are a regulatory T cell subset that controls antibody production by inhibiting T follicular helper (Tfh)–mediated help to B cells. Tfh and Tfr cells possess opposing functions suggesting unique programming. Here we elucidated the transcriptional program controlling Tfr suppressive function. We found that Tfr cells have a program for suppressive function fine-tuned by tissue microenvironment. The transcription factor FoxP3 and chromatin-modifying enzyme EZH2 are essential for this transcriptional program but regulate the program in distinct ways. FoxP3 modifies the Tfh program to induce a Tfr-like functional state, demonstrating that Tfr cells coopt the Tfh program for suppression. Importantly, we identified a Tfr cell population that loses the Tfr program to become “ex-Tfr” cells with altered functionality. These dysfunctional ex-Tfr cells may have roles in modulating pathogenic antibody responses. Taken together, our studies reveal mechanisms controlling the Tfr transcriptional program and how failure of these mechanisms leads to dysfunctional Tfr cells.